Mereo BioPharma Group plc
MREO
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.05M | -15.00M | -12.26M | -8.95M | -9.11M |
| Total Depreciation and Amortization | 274.00K | 282.00K | 257.00K | 275.00K | 281.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.51M | 8.58M | 2.44M | 2.19M | 4.14M |
| Change in Net Operating Assets | 857.00K | -1.38M | 1.66M | -1.51M | -2.10M |
| Cash from Operations | -9.42M | -7.52M | -7.90M | -7.99M | -6.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 1.00K | -700.00K | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 1.00K | -700.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 47.00M | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.00K | -594.00K | -219.00K | -- | 0.00 |
| Cash from Financing | -40.00K | -594.00K | 46.78M | -- | 0.00 |
| Foreign Exchange rate Adjustments | -1.26M | 1.20M | -107.00K | -70.00K | 1.68M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | -10.72M | -6.91M | 38.77M | -8.76M | -5.11M |